Clinical trial
A Cost-Benefit Analysis of EFNEP Utilizing Biomarkers of Chronic Disease Risk
NCT05558085 is registered in ClinicalTrials.gov with South Dakota State University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Cost-Benefit Analysis of EFNEP Utilizing Biomarkers of Chronic Disease Risk
- Lead sponsor
- South Dakota State University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 26, 2022
- Completion date
- December 31, 2024
- Enrollment
- 500 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.